SuperworthGRAIL market cap GRAL
Share price times shares outstanding: what the whole company sells for, since 2024.
- Today, Oct 23, 2026
- $5.9B
- Highest close in our data
- $6.4B
- Oct 2026
GRAIL is worth $5.9B at the close on Oct 23, 2026, at $132.55 a share.
That is up 84% over the last year.
Its highest close in our data was $6.4B in Oct 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $5.9B | $1.8B | $6.4B | +66% |
| 2025 | $3.6B | $585.3M | $4.3B | +442% |
| 2024 | $658.6M | $394M | $744.6M | n/a |
Against its peers
Companies in Medical - Diagnostics & Research nearest GRAIL's size, closest first, today.
| Company | Market cap |
|---|---|
| GRALGRAIL | $5.9B |
| LNTHLantheus | $6.5B |
| BLLNBillionToOne | $5.1B |
| CAICaris Life Sciences | $9B |
| VCYTVeracyte | $3.9B |
| CDNACareDx | $3.6B |
| BIOBio-Rad Laboratories | $9.9B |
| RVTYRevvity | $17.7B |
| MEDPMedpace | $18.7B |
| LHLabcorp | $26.7B |
| DGXQuest Diagnostics | $26.7B |
| Peer median | $9.5B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on GRAIL
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.